首页> 美国卫生研究院文献>PLoS Clinical Trials >Optimizing the production and affinity purification of HIV-1 envelope glycoprotein SOSIP trimers from transiently transfected CHO cells
【2h】

Optimizing the production and affinity purification of HIV-1 envelope glycoprotein SOSIP trimers from transiently transfected CHO cells

机译:从瞬时转染的CHO细胞中优化HIV-1包膜糖蛋白SOSIP三聚体的生产和亲和纯化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We describe methods to improve the efficiency with which HIV-1 Envelope glycoprotein SOSIP trimer immunogens can be produced by transient transfection of ExpiCHO-S cells and then affinity purified using the trimer-specific human monoclonal antibody PGT145. The specificity of PGT145 for properly folded trimers allows for the facile, one-step, isolation of these immunogens in research laboratories. PGT145 columns are also valuable as a component of more complex purification processes in current Good Manufacturing Practice programs. However, we found that PGT145 purification was highly variable and markedly inefficient when used to process supernatants from transiently transfected ExpiCHO-S cells expressing the BG505 SOSIP.664 and other trimeric Env proteins. In contrast, no such problems arose when the same Env proteins derived from a stable CHO cell line were processed on the same PGT145 columns, or with transient transfection supernatants from 293F cells. An investigation of the ExpiCHO-S transfection system identified the presence of polyanions, including but perhaps not limited to dextran sulfate, in the Enhancer component of the transfection system. We hypothesized that these polyanions bound to the cationic PGT145 epitope on the trimers and impeded their ability to bind to the PGT145 affinity column. We found that replacing the Enhancer component with alternative culture medium supplements substantially increased the yield of PGT145-purifiable trimers, and we also confirmed that both dextran sulfate and the Enhancer component were indeed inhibitors of PGT145 binding to BG505 SOSIP.664 trimers in immunoassays. The presence of polyanions, including but not limited to nucleic acids, should be considered in other circumstances where PGT145 columns are less efficient than expected at purifying native-like trimers.
机译:我们描述了提高效率的方法,可以通过瞬时转染ExpiCHO-S细胞来产生HIV-1信封糖蛋白SOSIP三聚体免疫原,然后使用三聚体特异性人单克隆抗体PGT145进行亲和纯化。 PGT145对适当折叠的三聚体的特异性允许在研究实验室中轻松,一步地分离这些免疫原。在当前的良好制造规范计划中,PGT145色谱柱作为更复杂的纯化过程的组成部分也很有价值。但是,我们发现,PGT145纯化用于处理表达BG505 SOSIP.664和其他三聚Env蛋白的瞬时转染的ExpiCHO-S细胞的上清液时,高度可变且效率低下。相反,当在相同的PGT145柱上处理来自稳定CHO细胞系的相同Env蛋白,或用293F细胞的瞬时转染上清液处理时,则不会出现此类问题。对ExpiCHO-S转染系统的研究确定了转染系统增强子组件中存在聚阴离子,包括但不限于硫酸葡聚糖。我们假设这些聚阴离子与三聚体上的阳离子PGT145表位结合,并阻碍了它们与PGT145亲和柱结合的能力。我们发现用替代培养基补充剂代替增强剂成分可大大提高PGT145可纯化三聚体的产量,并且我们还证实,在免疫测定中,硫酸葡聚糖和增强剂成分均确实是PGT145与BG505 SOSIP.664三聚体结合的抑制剂。在其他情况下,应考虑存在聚阴离子(包括但不限于核酸),而在其他情况下,PGT145色谱柱在纯化天然样三聚体方面效率不及预期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号